GlassScriptPhysician profile
Alan David Perry
NPI 1679563423
$8,452.16
in general payments reported to CMS, 2019-2025
38 companies · $2,396 in 2025
The $2,396 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $972 · 2020: $454 · 2021: $360 · 2022: $583 · 2023: $1,655 · 2024: $2,034 · 2025: $2,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,084.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,496.36 | 2019-2025 | Apretude, Dovato, Cabenuva |
| Gilead Sciences, INC. | $1,372.18 | 2019-2025 | Biktarvy |
| Novo Nordisk INC | $928.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $731.04 | 2020-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Lilly USA, LLC | $666.11 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $410.88 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $390.89 | 2019-2025 | Delstrigo, Pifeltro, Dificid |
| Astrazeneca Pharmaceuticals LP | $317.82 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $287.71 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $173.41 | 2023-2025 | |
| Exact Sciences Corporation | $166.53 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $156.62 | 2019-2023 | Spravato |
| Glaxosmithkline, LLC. | $136.50 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.29 | 2019-2024 | Synjardy, Jardiance, Ofev |
| Sanofi-Aventis U.S. LLC | $105.73 | 2019-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan David Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.